We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

CorVel CEO Combs Exercises Options for 9,360 Shares

Michael G. Combs, CEO and President of CorVel Corp, filed a Form 4 on November 9, 2026, reporting multiple stock option exercises and related share disposals that occurred on November 6, 2026.

Shwetambri Chauhan | 09 November 2026

Jennifer Yoss Receives 2,200 Stock Options at $85.91

CorVel Corp Vice President of Accounting Jennifer Yoss filed a Form 4 on November 9, 2026, disclosing the acquisition of 2,200 non-qualified stock options in CorVel Corp (NASDAQ:CRVL) on November 5, 2026.

Vinay Lochav | 09 November 2026

Holley Receives 184.614 RSU Shares in Amgen Director Grant

Director Charles M. Holley filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 184.614 shares of Amgen Inc. common stock through a restricted stock unit grant at no cost.

Aditi Sarkar | 09 November 2026

Fleming Buys 250 Class B Shares of Construction Partners at $88.33

Ned N. Fleming III, a director and 10% owner of Construction Partners, Inc. (NASDAQ:ROAD), filed a Form 4 on November 9, 2026, disclosing a privately negotiated purchase of 250 shares of Class B common stock at $88.33 per share on November 9, 2026.

Manish Choudhary | 09 November 2026

Amgen Director Ishrak Acquires 152 RSU Shares on Nov 6

Director Omar Ishrak filed a Form 4 with the SEC on November 7, 2026, reporting the acquisition of 152.0351 shares of Amgen Inc. common stock on November 6, 2026, through a vested Restricted Stock Unit grant at no cost.

Aditi Sarkar | 09 November 2026

ADAR1 Capital Buys 2,640 InMed Shares at $13.0953

ADAR1 Capital Management, LLC and Daniel Schneeberger filed a Form 4 on November 9, 2026, disclosing a purchase of 2,640 common shares of InMed Pharmaceuticals Inc. (now Mentari Therapeutics, Inc.) on November 5, 2026, at a weighted average price of $13.0953 per share.

Manish Choudhary | 09 November 2026

Karat Packaging CFO Guo Jian Buys 162 Shares via UTMA Account

Karat Packaging Inc. Chief Financial Officer and Director Guo Jian filed a Form 4 on November 9, 2026, disclosing a purchase of 162 shares of common stock through a custodial account established under the Uniform Transfer to Minors Act.

Manish Choudhary | 09 November 2026

Oconnor Julie Allison Gets 2,500 RSUs at MVB Financial

MVB Financial Corp's Chief Risk and Compliance Officer, Julie Allison Oconnor, filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 2,500 restricted stock units on November 5, 2026.

Anjali Anand | 09 November 2026

Bhandari Receives 12,980 Class B Shares From Houlihan Lokey

Prabha S. Bhandari, Chief Legal Officer and Secretary of Houlihan Lokey, Inc. (NYSE:HLI), filed a Form 4 on November 9, 2026, disclosing three equity grants of Class B Common Stock made on November 5, 2026, totaling 12,980 shares, plus a concurrent disposition of 12,980 …

Nitish Kishor | 09 November 2026

Fund 1 Investments Sells 750,000 Citi Trends Shares at $45.76

Fund 1 Investments, LLC filed a Form 4 with the SEC on November 9, 2026, reporting the sale of 750,000 shares of Citi Trends Inc common stock on November 5, 2026.

Aditi Sarkar | 09 November 2026
Support

Hi! How can we help you today?

Loading…